Inventor · disambiguated record
Matthew Peterson
Also filed as: PETERSON MATTHEW · PETERSON MATTHEW W
8 granted patents·4 pending applications·20 citations·filing 2007–2024
79Inventor score
Top patents by PatentIndex Score
12 records- 0193US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0292US11827600B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2022·Granted Nov 28, 2023·3 cites·19 claims
- 0381US11142516B2Process for the preparation of an amino-pyrimidine and intermediates thereofCYTOKINETICS INC·Filed 2018·Granted Oct 12, 2021·1 cites·29 claims
- 0473US12492167B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2023·Granted Dec 9, 2025·0 cites·39 claims
- 0571US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 0657US2022098150A1Novel Crystalline FormsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0756US7632963B2Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamateJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Dec 15, 2009·0 cites·14 claims
- 0855US9981988B2Polymorphic forms and co-crystals of a c-Met inhibitorAMGEN INC·Filed 2016·Granted May 29, 2018·0 cites·3 claims
- 0953US10344041B2Polymorphic forms and co-crystals of a c-Met inhibitorAMGEN INC·Filed 2018·Granted Jul 9, 2019·0 cites·9 claims
- 1053US10053452B2Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereofAMGEN INC·Filed 2014·Granted Aug 21, 2018·0 cites·13 claims
- 1152US2022315558A1Polymorphs of 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamideCYTOKINETICS INC·Filed 2020·Application pending·0 cites
- 1248US2020062705A1Novel crystalline formsBIOGEN MA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Peterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →